Mayo Clinic Develops Milk-Derived Nanoparticles for Targeted Cholangiocarcinoma Treatment
Researchers at Mayo Clinic have engineered milk-derived nanoparticles to enhance the delivery of therapies directly to cholangiocarcinoma tumors, potentially improving treatment efficacy.